Revista de Neurología,
Journal Year:
2024,
Volume and Issue:
79(02), P. 51 - 51
Published: Jan. 1, 2024
The
XVI
Post-ECTRIMS
meeting
was
held
in
Seville
on
20
and
21
October
2023,
where
expert
neurologists
multiple
sclerosis
(MS)
summarised
the
main
new
developments
presented
at
ECTRIMS
2023
congress,
which
took
place
Milan
from
11
to
13
October.
aim
of
this
article
is
summarise
content
Meeting,
an
two
parts.
This
second
part
covers
health
women
elderly
MS
patients,
trends
treatment
cognitive
impairment,
focusing
particularly
meditation,
neuroeducation
rehabilitation,
introduces
concept
fatigability,
has
been
used
a
limited
extent
MS.
key
role
digitalization
artificial
intelligence
theoretically
near
future
subject
debate,
along
with
potential
these
technologies
can
offer.
most
recent
research
various
algorithms
their
efficacy
safety
management
disease
reviewed.
Finally,
relevant
data
for
cladribine
evobrutinib
are
presented,
as
well
therapeutic
strategies
currently
being
investigated.
Neurologie pro praxi,
Journal Year:
2024,
Volume and Issue:
25(1), P. 62 - 65
Published: March 6, 2024
V
současné
době
se
mění
pohled
na
léčbu
roztroušené
sklerózy.
U
indikovaných
pacientů
je
cílem
nasazení
vysoce
účinné
léčby
v
rané
fázi
nemoci.
Zvyšuje
počet
této
léčbě
i
spektrum
léčiv.
Ofatumumab
jedním
z
účinných
léků.
Jde
o
monoklonální
protilátku
proti
CD20
lymfocytům
s
prokázanou
vysokou
a
rychlou
účinností
potlačení
zánětlivé
aktivity,
ale
částečně
progrese
onemocnění
bez
relapsů.
Byť
dobře
tolerován,
což
umožňuje
aplikaci
pacientem
domácím
prostředí,
stále
jedná
lék
působící
selektivní
imunosupresi
potenciálními
nežádoucími
účinky,
tedy
nutností
farmakovigilance.
Cílem
článku
upozornit
neurology
praktické
aspekty
léčby.
The Nurse Practitioner,
Journal Year:
2024,
Volume and Issue:
49(7), P. 38 - 47
Published: June 25, 2024
The
treatment
landscape
for
multiple
sclerosis
has
dramatically
grown
in
terms
of
available
options
and
complexity.
various
mechanisms
action
safety
profiles
these
new
treatments
necessitate
that
primary
care
providers
remain
current
knowledge
practice
to
provide
high-quality
care.
Revista de Neurología,
Journal Year:
2024,
Volume and Issue:
79(02), P. 51 - 51
Published: Jan. 1, 2024
The
XVI
Post-ECTRIMS
meeting
was
held
in
Seville
on
20
and
21
October
2023,
where
expert
neurologists
multiple
sclerosis
(MS)
summarised
the
main
new
developments
presented
at
ECTRIMS
2023
congress,
which
took
place
Milan
from
11
to
13
October.
aim
of
this
article
is
summarise
content
Meeting,
an
two
parts.
This
second
part
covers
health
women
elderly
MS
patients,
trends
treatment
cognitive
impairment,
focusing
particularly
meditation,
neuroeducation
rehabilitation,
introduces
concept
fatigability,
has
been
used
a
limited
extent
MS.
key
role
digitalization
artificial
intelligence
theoretically
near
future
subject
debate,
along
with
potential
these
technologies
can
offer.
most
recent
research
various
algorithms
their
efficacy
safety
management
disease
reviewed.
Finally,
relevant
data
for
cladribine
evobrutinib
are
presented,
as
well
therapeutic
strategies
currently
being
investigated.
